Browsing by Author "Lerebours, Reginald"
Now showing 1 - 14 of 14
- Results Per Page
- Sort Options
Item Open Access A mathematical framework to quantitatively balance clinical and radiation risk in Computed Tomography(2021-12-01) Ria, Francesco; Zhang, Anru; Lerebours, Reginald; Erkanli, Alaattin; Solomon, justin; Marin, Daniele; Samei, EhsanPurpose: Risk in medical imaging is a combination of radiation risk and clinical risk, which is largely driven by the effective diagnosis. While radiation risk has traditionally been the main focus of Computed Tomography (CT) optimization, such a goal cannot be achieved without considering clinical risk. The purpose of this study was to develop a comprehensive mathematical framework that considers both radiation and clinical risks based on the specific task, the investigated disease, and the interpretive performance (i.e., false positive and false negative rates), tested across a representative clinical CT population. Methods and Materials: The proposed mathematical framework defined the radiation risk to be a linear function of the radiation dose, the population prevalence of the disease, and the false positive rate. The clinical risk was defined to be a function of the population prevalence, the expected life-expectancy loss for an incorrect diagnosis, and the interpretative performance in terms of the AUC as a function of radiation dose. A Total Risk (TR) was defined as the sum of the radiation risk and the clinical risk. With IRB approval, the mathematical function was applied to a dataset of 80 adult CT studies investigating localized stage liver cancer (LLC) for a specific false positive rate of 5% reconstructed with both Filtered Back Projection (FBP) and Iterative Reconstruction (IR) algorithm. Linear mixed effects models were evaluated to determine the relationship between radiation dose and radiation risk and interpretative performance, respectively. Lastly, the analytical minimum of the TR curve was determined and reported. Results: TR is largely affected by clinical risk for low radiation dose whereas radiation risk is dominant at high radiation dose. Concerning the application to the LLC population, the median minimum risk in terms of mortality per 100 patients was 0.04 in FBP and 0.03 in IR images; the corresponding CTDIvol values were 38.5 mGy and 25.7 mGy, respectively. Conclusions: The proposed mathematical framework offers a complete quantitative description of risk in CT enabling a comprehensive risk-to-benefit assessment essential in the effective justification of radiological procedures and in the design of optimal clinical protocols. Clinical Relevance/Application: The quantification of both radiation and clinical risk using comparable units allows the calculation of the overall risk paving the road towards a comprehensive risk-to-benefit assessment in CT.Item Open Access Association and Trends in Medicare Denials and Utilization for Brain CT: Indirect Impacts by Targeted Policy Intervention?(Current problems in diagnostic radiology, 2022-07-30) French, Robert J; Hirsch, Joshua; Hemingway, Jennifer; Hughes, Danny R; Lerebours, Reginald; Luo, Sheng; Allen, Brian C; Duszak, Richard; Rosman, David ATwenty-five years of annual Medicare Physician/Supplier Procedure Summary (PSPS) Master File data were used to assess trends in normalized volume and claim denial rates for brain computerized tomography. Alongside growth in utilization of brain computerized tomography (services, denial rates, fell from 1999-2005 and with relatively leveled growth and less denial rate volatility thereafter. More recent trends in denial rates may be related to policy interventions initially aimed at cost and volume reduction.Item Open Access Automated Structured Reporting for Thyroid Ultrasound: Effect on Reporting Errors and Efficiency.(Journal of the American College of Radiology : JACR, 2020-08-17) Wildman-Tobriner, Benjamin; Ngo, Lawrence; Jaffe, Tracy A; Ehieli, Wendy L; Ho, Lisa M; Lerebours, Reginald; Luo, Sheng; Allen, Brian CPURPOSE:To compare the effectiveness of different reporting templates using the ACR Thyroid Imaging Reporting and Data System (TI-RADS) for thyroid ultrasound. METHODS:In this retrospective study, four radiologists implemented ACR TI-RADS while dictating 20 thyroid ultrasounds for each of four different templates: free text, minimally structured, fully structured, fully structured and automated (embedded software automatically sums TI-RADS points, correlates with nodule size, and inserts appropriate recommendation into report impression). In total, 80 reports were constructed per template type. Frequencies of different errors related to ACR TI-RADS were recorded: errors in point assignment, point addition, risk-level assignment, and recommendation. Reporting times were recorded, and a survey about using the template was administered. Differences in error rates were compared using χ2 and Fisher's exact tests, and differences in reporting times were compared using Kruskal-Wallis tests. RESULTS:Across all readers, errors were identified in 27.5% of reports (22 of 80) for the free text template, 28.8% (23 of 80) for the minimally structured template, 18.8% (15 of 80) for the fully structured template, and 0% (0 of 80) for the fully structured and automated template (P < .0001). Frequency of each error type (number assignment, addition, TR categorization, recommendation) decreased across the four templates (P < .0005 to P < .005). Median reporting times for the less complex templates were 210 to 240 seconds, whereas the median automated template reporting time was 180 seconds (P = .41). Radiologists subjectively preferred using the automated template. CONCLUSION:A structured reporting template for thyroid ultrasound that automatically executed steps of ACR TI-RADS resulted in fewer reporting errors for radiologists.Item Open Access Bacteremia in solid organ transplant recipients as compared to immunocompetent patients: Acute phase cytokines and outcomes in a prospective, matched cohort study.(American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2021-06) Eichenberger, Emily M; Ruffin, Felicia; Dagher, Michael; Lerebours, Reginald; Jung, Sin-Ho; Sharma-Kuinkel, Batu; Macintyre, Andrew N; Thaden, Joshua T; Sinclair, Matthew; Hale, Lauren; Kohler, Celia; Palmer, Scott M; Alexander, Barbara D; Fowler, Vance G; Maskarinec, Stacey AWe undertook a prospective, matched cohort study of patients with Staphylococcus aureus bacteremia (SAB) and gram-negative bacteremia (GNB) to compare the characteristics, outcomes, and chemokine and cytokine response in transplant recipients to immunocompetent, nontransplant recipients. Fifty-five transplant recipients (GNB n = 29; SAB n = 26) and 225 nontransplant recipients (GNB n = 114; SAB n = 111) were included for clinical analysis. Transplant GNB had a significantly lower incidence of septic shock than nontransplant GNB (10.3% vs 30.7%, p = .03). Thirty-day mortality did not differ significantly between transplant and nontransplant recipients with GNB (10.3% vs 15.8%, p = .57) or SAB (0.0% vs 11.7%, p = .13). Next, transplant patients were matched 1:1 with nontransplant patients for the chemokine and cytokine analysis. Five cytokines and chemokines were significantly lower in transplant GNB vs nontransplant GNB: IL-2 (median [IQR]: 7.1 pg/ml [7.1, 7.1] vs 32.6 pg/ml [7.1, 88.0]; p = .001), MIP-1β (30.7 pg/ml [30.7, 30.7] vs 243.3 pg/ml [30.7, 344.4]; p = .001), IL-8 (32.0 pg/ml [5.6, 53.1] vs 59.1 pg/ml [39.2, 119.4]; p = .003), IL-15 (12.0 pg/ml [12.0, 12.0] vs 12.0 pg/ml [12.0, 126.7]; p = .03), and IFN-α (5.1 pg/mL [5.1, 5.1] vs 5.1 pg/ml [5.1, 26.3]; p = .04). Regulated upon Activation, Normal T Cell Expressed and Secreted (RANTES) was higher in transplant SAB vs nontransplant SAB (mean [SD]: 750.2 pg/ml [194.6] vs 656.5 pg/ml [147.6]; p = .046).Item Open Access Clinical and radiation risk across one million patients in Computed Tomography: influence of age, size, and race(2023-11-26) Ria, Francesco; Lerebours, Reginald; Zhang, Anru; Erkanli, Alaattin; Abadi, Ehsan; SOLOMON, justin; Marin, Daniele; Samei, EhsanPurpose. We recently developed a mathematical model to balance radiation risk and clinical risk, namely the risk of misdiagnosis due to insufficient image quality. In this work, we applied this model to a population of one million CT imaging cases to evaluate the risk stratification with different ages, sexes, and races. Materials and Methods. The demographics were informed by literature and census information simulating a clinical liver cancer population. The Total Risk (TR) was calculated as the linear combination of radiation risk and clinical risk. The model included factors for the radiation burden for different age and sex; the prevalence of the disease; the false positive rate; the expected life-expectancy loss for an incorrect diagnosis for different ages, sex, and race; and a typical false positive rate of 5%. It was assumed that each case received an average radiologist interpretative performance of 0.75 AUC for a hypothetical lesion without any changes in radiation dose beyond routine practice. We further, for each patient, simulated 2,000 imaging conditions with CTDIvol varying from 0.1 and 200 mGy with 0.1 mGy increments. Per each CTDIvol value, the anticipated AUC was calculated by applying the established asymptotic relationships between CTDIvol and image quality. The AUC distribution was then used to calculate the theoretical minimum total risk (TRmin) per each patient. Results. For the routine practice, the median theoretical total risk was estimated to be 0.058 deaths per 100 patients (range: 0.002 – 0.154) comprising of the median radiation risk of 0.009 (range: 0.001 – 0.069), and of the median clinical risk of 0.049 (range: 7.0x10-5 – 0.094). Considering the varying scanner output conditions, the median TRmin was 0.054 deaths per 100 patients for White male patients, 0.054 for Blacks, 0.057 for Hispanics, and 0.065 for Asians. For female patients, the median TRmin values were 0.049, 0.056, 0.054, and 0.061 deaths per 100 patients, respectively. Conclusion. For each demography condition, the clinical risk was found to largely outweigh the radiation risk by at least 500%. Total risk showed different stratifications with patient age and race. Clinical Relevance Statement. To optimize CT conditions for specific patients and/or population, both radiation risk and clinical risks should be all accounted for together with demographic information. We demonstrated a methodology that allows a complete depiction of total risk in CT, considering radiation and clinical risks at comparable units, and patient demographic.Item Open Access Comparative Risk Assessment of Clinical and Radiation Risk across a Cohort of Patient and Individualized Risk Optimization(https://aapm.onlinelibrary.wiley.com/doi/epdf/10.1002/mp.16525, 2023-07-23) Ria, Francesco; Lerebours, Reginald; Zhang, Anru; Erkanli, Alaattin; Abadi, Ehsan; SOLOMON, justin; Marin, daniele; Samei, EhsanPurpose Informed by a recent mathematical framework, we formulated an imaging strategy to balance interpretative performance-based clinical risk (i.e., false positive and false negative rates) and radiation risk as a risk-versus-risk assessment. The model was applied to a population of one million cases simulating a clinical liver cancer scenario. Moreover, a model was developed to predict individualized risk-versus-risk optimization. Methods The proposed model defined a Total Risk (TR) as the linear combination of radiation risk and clinical risk defined as functions of the radiation burden, the disease prevalence disease, the false positive rate, the expected life-expectancy loss for an incorrect diagnosis, and the radiologist interpretative performance (i.e., AUC). The mathematical framework was applied to a simulated dataset of 1,000,000 CT studies investigating localized stage liver cancer assuming a typical false positive rate of 5% and optimal imaging conditions (AUC=0.75). Demographic information was simulated according with literature and census data including male and female for different patient races (white, black, Asian, and Hispanic). Following BEIR-VII report, organ-specific radiation doses were used to calculate the radiation Risk Index per each patient. The model was then extended to predict the optimal scanner output associated with the TR for specific patients. Results Across all races and sexes, median radiation risk ranged between 0.008 and 0.012 number of deaths per 100 patients; median clinical risk ranged between 0.042 and 0.076; and medial total risk ranged between 0.010 and 0.088 deaths per 100 patients. The mathematical model was then generalized to estimate individualized optimal imaging condition minimizing TR. Conclusion A mathematical framework to describe total risk in CT was robustly tested in a simulated dataset of 1,000,000 CT studies. The results highlighted the dominance of clinical risk at typical CT examination dose levels. The generalization of the mathematical model allowed the prediction of individualized risk optimization.Item Open Access Correlation of pre-operative imaging characteristics with donor outcomes and operative difficulty in laparoscopic donor nephrectomy.(American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2019-09-25) Schwartz, Fides R; Shaw, Brian I; Lerebours, Reginald; Vernuccio, Federica; Rigiroli, Francesca; Gonzalez, Fernando; Luo, Sheng; Rege, Aparna S; Vikraman, Deepak; Hurwitz-Koweek, Lynne; Marin, Daniele; Ravindra, KadiyalaThis study aimed to understand the relationship of pre-operative measurements and risk factors on operative time and outcomes of laparoscopic donor nephrectomy. 242 kidney donors between 2010 and 2017 were identified. Patient's demographic, anthropomorphic and operative characteristics were abstracted from the electronic medical record. Glomerular filtration rates (GFR) were documented before surgery, within 24 hours, 6, 12 and 24 months after surgery. Standard radiological measures and kidney volumes, subcutaneous and perinephric fat thicknesses were assessed by three radiologists. Data were analyzed using standard statistical measures. There was significant correlation between cranio-caudal and latero-lateral diameters (p<0.0001) and kidney volume. The left kidney was transplanted in 92.6% of cases and the larger kidney in 69.2%. Kidney choice (smaller vs larger) had no statistically significant impact on the rate of change of donor kidney function over time adjusting for age, sex and race (p=0.61). Perinephric fat thickness (+4.08 min) and surgery after 2011 were significantly correlated with operative time (p≤0.01). In conclusion, cranio-caudal diameters can be used as a surrogate measure for volume in the majority of donors. Size may not be a decisive factor for long-term donor kidney function. Perinephric fat around the donor kidney should be reported to facilitate operative planning.Item Open Access Cross-sectional CT Assessment of the Extent of Injectate Spread at CT Fluoroscopy-guided Cervical Epidural Interlaminar Steroid Injections.(Radiology, 2019-07-16) Amrhein, Timothy J; Bozdogan, Erol; Vekaria, Sunit; Patel, Prasad; Lerebours, Reginald; Luo, Sheng; Kranz, Peter GBackground Previous studies analyzed contrast agent spread during cervical interlaminar epidural steroid injections (CILESIs) by using planar fluoroscopy and reported wide variance of the rate of spread to the ventral epidural space (VES). Cross-sectional CT allows for direct viewing of contrast agent in the VES, providing improved spread assessment and thereby informing needle placement decisions when targeting pain generators. Purpose To determine the extent of injectate spread at CT fluoroscopy-guided CILESI, with particular attention to the VES and bilateral neuroforamina, by using cross-sectional CT. Materials and Methods This study reviewed 83 consecutive CT fluoroscopy-guided CILESIs at which a postprocedural cervical spine CT was performed (June 2016 to December 2017). All procedures used the same injectate (2 mL corticosteroid, 3 mL contrast agent). Postprocedural CT scans were reviewed for the presence of contrast within the VES, dorsal epidural space, ipsilateral neuroforamen, and contralateral neuroforamen in every cervical interlaminar level. Descriptive data are presented as frequencies or means. McNemar tests or hierarchical logistic models were used to assess associations between covariates and contrast agent spread to particular locations. Results The study cohort included 73 individual patients (59% women; 43 of 73) (mean patient age, 57.6 years ± 11.5 [standard deviation]). Mean number of levels of cranial spread were 0.6 level for VES, 1.9 levels for contralateral neuroforamen, 2.1 levels for ipsilateral neuroforamen, and 3 levels for dorsal epidural space. No VES spread in any level was found with 35% (29 of 83) of injections. VES spread was more likely to occur in the level of needle placement (43%; 36 of 83) than in other interlaminar levels (19.5%; 97 of 498; P < .001). Spread was more likely to occur in the neuroforamen ipsilateral to the needle approach compared with contralateral (P < .001). Conclusion Cervical interlaminar epidural steroid injections have injectate spreads with a mean of less than one level cranially in the ventral epidural space (VES) and approximately two levels in the neuroforamen. VES spread occurs more frequently at the level of needle placement and within the ipsilateral neuroforamen. © RSNA, 2019.Item Open Access CT Radiomic Features of Superior Mesenteric Artery Involvement in Pancreatic Ductal Adenocarcinoma: A Pilot Study.(Radiology, 2021-09-07) Rigiroli, Francesca; Hoye, Jocelyn; Lerebours, Reginald; Lafata, Kyle J; Li, Cai; Meyer, Mathias; Lyu, Peijie; Ding, Yuqin; Schwartz, Fides R; Mettu, Niharika B; Zani, Sabino; Luo, Sheng; Morgan, Desiree E; Samei, Ehsan; Marin, DanieleBackground Current imaging methods for prediction of complete margin resection (R0) in patients with pancreatic ductal adenocarcinoma (PDAC) are not reliable. Purpose To investigate whether tumor-related and perivascular CT radiomic features improve preoperative assessment of arterial involvement in patients with surgically proven PDAC. Materials and Methods This retrospective study included consecutive patients with PDAC who underwent surgery after preoperative CT between 2012 and 2019. A three-dimensional segmentation of PDAC and perivascular tissue surrounding the superior mesenteric artery (SMA) was performed on preoperative CT images with radiomic features extracted to characterize morphology, intensity, texture, and task-based spatial information. The reference standard was the pathologic SMA margin status of the surgical sample: SMA involved (tumor cells ≤1 mm from margin) versus SMA not involved (tumor cells >1 mm from margin). The preoperative assessment of SMA involvement by a fellowship-trained radiologist in multidisciplinary consensus was the comparison. High reproducibility (intraclass correlation coefficient, 0.7) and the Kolmogorov-Smirnov test were used to select features included in the logistic regression model. Results A total of 194 patients (median age, 66 years; interquartile range, 60-71 years; age range, 36-85 years; 99 men) were evaluated. Aside from surgery, 148 patients underwent neoadjuvant therapy. A total of 141 patients' samples did not involve SMA, whereas 53 involved SMA. A total of 1695 CT radiomic features were extracted. The model with five features (maximum hugging angle, maximum diameter, logarithm robust mean absolute deviation, minimum distance, square gray level co-occurrence matrix correlation) showed a better performance compared with the radiologist assessment (model vs radiologist area under the curve, 0.71 [95% CI: 0.62, 0.79] vs 0.54 [95% CI: 0.50, 0.59]; P < .001). The model showed a sensitivity of 62% (33 of 53 patients) (95% CI: 51, 77) and a specificity of 77% (108 of 141 patients) (95% CI: 60, 84). Conclusion A model based on tumor-related and perivascular CT radiomic features improved the detection of superior mesenteric artery involvement in patients with pancreatic ductal adenocarcinoma. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Do and Kambadakone in this issue.Item Open Access Ideal high sensitivity troponin baseline cutoff for patients with renal dysfunction.(The American journal of emergency medicine, 2022-06) Limkakeng, Alexander T; Hertz, Julian; Lerebours, Reginald; Kuchibhatla, Maragatha; McCord, James; Singer, Adam J; Apple, Fred S; Peacock, William F; Christenson, Robert H; Nowak, Richard MItem Open Access MRI Quantification of Placebo Effect in Nonalcoholic Steatohepatitis Clinical Trials.(Radiology, 2022-11) Nedrud, Marybeth A; Chaudhry, Mohammad; Middleton, Michael S; Moylan, Cynthia A; Lerebours, Reginald; Luo, Sheng; Farjat, Alfredo; Guy, Cynthia; Loomba, Rohit; Abdelmalek, Manal F; Sirlin, Claude B; Bashir, Mustafa RBackground Several early-phase clinical trials for the treatment of nonalcoholic steatohepatitis (NASH) use liver fat content as measured with the MRI-derived proton density fat fraction (PDFF) for a primary outcome. These trials have shown relative reductions in liver fat content with placebo treatment alone, a phenomenon termed "the placebo effect." This phenomenon confounds the results and limits generalizability to future trials. Purpose To quantify the effect of placebo treatment on change in the absolute PDFF value and to identify variables associated with this observed change. Materials and Methods This is a secondary analysis of prospectively collected data from seven early phase clinical trials that included participants with a diagnosis of NASH based on MRI and/or liver biopsy who received placebo treatment. The primary outcome was a greater than or equal to 30% relative reduction in PDFF after placebo treatment. Normalization of PDFF, relative change in alanine aminotransferase (ALT) level, and normalization of ALT level were also examined. An exploratory linear mixed-effects model was used to estimate an overall change in absolute PDFF and to explore parameters associated with this response. Results A total of 187 participants (median age, 52 years [IQR, 43-60 years]; 114 women) who received placebo treatment were evaluated. A greater than or equal to 30% relative reduction in baseline PDFF was seen in 20% of participants after 12 weeks of placebo treatment (10 of 49), 9% of participants after 16 weeks (two of 22), and 28% of participants after 24 weeks (34 of 122). A repeated-measures linear mixed-effects model estimated a decrease of 2.3 units (median relative reduction of 13%) in absolute PDFF values after 24 weeks of placebo treatment (95% CI: 3.2, 1.4; P < .001). Conclusion In this analysis of 187 participants, a clinically relevant decrease in PDFF was observed with placebo treatment. Based on the study model, assuming an absolute PDFF decrease of approximately 3 units (upper limit of 95% CI) to account for this "placebo effect" in sample size calculations for future clinical trials is suggested. Clinical trial registration nos. NCT01066364, NCT01766713, NCT01963845, NCT02443116, NCT02546609, NCT02316717, and NCT02442687 © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Yoon in this issue.Item Open Access Optimization of abdominal CT based on a model of total risk minimization by putting radiation risk in perspective with imaging benefit.(Communications medicine, 2024-12) Ria, Francesco; Zhang, Anru R; Lerebours, Reginald; Erkanli, Alaattin; Abadi, Ehsan; Marin, Daniele; Samei, EhsanBackground
Risk-versus-benefit optimization required a quantitative comparison of the two. The latter, directly related to effective diagnosis, can be associated to clinical risk. While many strategies have been developed to ascertain radiation risk, there has been a paucity of studies assessing clinical risk, thus limiting the optimization reach to achieve a minimum total risk to patients undergoing imaging examinations. In this study, we developed a mathematical framework for an imaging procedure total risk index considering both radiation and clinical risks based on specific tasks and investigated diseases.Methods
The proposed model characterized total risk as the sum of radiation and clinical risks defined as functions of radiation burden, disease prevalence, false-positive rate, expected life-expectancy loss for misdiagnosis, and radiologist interpretative performance (i.e., AUC). The proposed total risk model was applied to a population of one million cases simulating a liver cancer scenario.Results
For all demographics, the clinical risk outweighs radiation risk by at least 400%. The optimization application indicates that optimizing typical abdominal CT exams should involve a radiation dose increase in over 90% of the cases, with the highest risk optimization potential in Asian population (24% total risk reduction; 306% CTDIvol increase) and lowest in Hispanic population (5% total risk reduction; 89% CTDIvol increase).Conclusions
Framing risk-to-benefit assessment as a risk-versus-risk question, calculating both clinical and radiation risk using comparable units, allows a quantitative optimization of total risks in CT. The results highlight the dominance of clinical risk at typical CT examination dose levels, and that exaggerated dose reductions can even harm patients.Item Open Access Optimization of imaging as a risk-versus-risk framework of quantitative balance between clinical and radiation risk: a task-based implementation for liver CT in a large demographic population(2022-11-30) Ria, Francesco; Lerebours, Reginald; Zhang, Anru; Erkanli, Alaattin; Marin, Daniele; Samei, EhsanItem Open Access The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma.(Radiology, 2019-12-17) Chaudhry, Mohammad; McGinty, Katrina A; Mervak, Benjamin; Lerebours, Reginald; Li, Cai; Shropshire, Erin; Ronald, James; Commander, Leah; Hertel, Johann; Luo, Sheng; Bashir, Mustafa R; Burke, Lauren MBBackground The Liver Imaging Reporting and Data System (LI-RADS) treatment response algorithm (TRA) is used to assess presumed hepatocellular carcinoma (HCC) after local-regional therapy, but its performance has not been extensively assessed. Purpose To assess the performance of LI-RADS version 2018 TRA in the evaluation of HCC after ablation. Materials and Methods In this retrospective study, patients who underwent ablation therapy for presumed HCC followed by liver transplantation between January 2011 and December 2015 at a single tertiary care center were identified. Lesions were categorized as completely (100%) or incompletely (≤99%) necrotic based on transplant histology. Three radiologists assessed pre- and posttreatment MRI findings using LI-RADS version 2018 and the TRA, respectively. Interreader agreement was assessed by using the Fleiss κ test. Performance characteristics for predicting necrosis category based on LI-RADS treatment response (LR-TR) category (viable or nonviable) were calculated by using generalized mixed-effects models to account for clustering by subject. Results A total of 36 patients (mean age, 58 years ± 5 [standard deviation]; 32 men) with 53 lesions was included. Interreader agreement for pretreatment LI-RADS category was 0.40 (95% confidence interval [CI]: 0.15, 0.67; P < .01) and was lower than the interreader agreement for TRA category (κ = 0.71; 95% CI: 0.59, 0.84; P < .01). After accounting for clustering by subject, sensitivity of tumor necrosis across readers ranged from 40% to 77%, and specificity ranged from 85% to 97% when LR-TR equivocal assessments were treated as nonviable. When LR-TR equivocal assessments were treated as viable, sensitivity of tumor necrosis across readers ranged from 81% to 87%, and specificity ranged from 81% to 85% across readers. Six (11%) of 53 treated lesions were LR-TR equivocal by consensus, with most (five of six) incompletely necrotic at histopathology. Conclusion The Liver Imaging Reporting and Data System treatment response algorithm can be used to predict viable or nonviable hepatocellular carcinoma after ablation. Most ablated lesions rated as treatment response equivocal were incompletely necrotic at histopathology. © RSNA, 2019 Online supplemental material is available for this article. See also the editorial by Do and Mendiratta-Lala in this issue.